Affirma Capital and StonePine ACE Partners announce final closing of investment

Affirma Capital and StonePine ACE Partners announce final closing of investment

Singapore / Egypt – Affirma Capital and StonePine ACE Partners Limited (“StonePine”) have announced the final closing of their USD 20 million investment to acquire a significant minority stake in Nerhadou International for Pharmaceuticals and Nutraceuticals (“Nerhadou” or the “Company”), one of the largest and fastest growing nutraceutical and pharmaceutical players and a pioneer oral dispersible film (“ODF”) manufacturer in Egypt.

Nerhadou has had a very strong performance over the past 12 months delivering double digit growth and continuing to grow and cement its position as a leading player across key nutraceutical product subsegments and ODF technology in Egypt. The Company has an attractive product pipeline consisting of several innovative nutraceutical and pharmaceutical products, both in ODF and conventional dosage forms. The fresh capital injected into the Company further strengthens its balance sheet for the future and will allow it to accelerate the roll-out of key growth initiatives.

Nerhadou is the first joint investment by Affirma Capital and StonePine Capital Partners in Egypt and is part of a broader Egypt focused joint investment strategy.

Affirma Capital and StonePine Capital Partners are committed to backing regional champions with strong management teams and founders and continue to actively seek suitable investment opportunities in Egypt and